A

Angitia

Clinical-stage biotech developing bone therapeutics

Scientist to Senior Scientist - Discovery Research

Translational Research & Bench BiologyConfirmed live in the last 24 hours
Full-timeGuangzhou, Guangdong Province, ChinaNo salary listedIn-person

About the Job

Requirements

  • Strong hands-on experience in antibody discovery, including animal immunization strategy design and execution and hybridoma-based antibody generation and screening.
  • Deep understanding and proficient application of antibody screening and functional assays, including ELISA, flow cytometry, and cell-based assays.
  • PhD in Immunology, Biology, Pharmacy, or a related field is preferred/required; a Master's degree with extensive relevant experience may also be considered.
  • Scientist level: PhD with at least 3 years, or Master's with 6–8 years, of relevant antibody discovery experience.
  • Senior Scientist level: PhD with at least 6 years, or Master's with at least 9 years, of relevant antibody discovery and/or platform development experience.
  • Exceptional candidates may be considered with flexibility on years of experience, based on project depth and actual deliverables.
  • Proficiency in oral and written English communication.

Responsibilities

  • Design and execute innovative antibody discovery projects, covering the workflow from immunization through candidate selection.
  • Drive antibody discovery using conventional approaches, including design and optimization of animal immunization strategies, hybridoma generation, screening and cloning, and antibody functional screening.
  • Establish and implement single B cell-based antibody discovery workflows, including single B cell sorting, sample preparation, single-cell screening and recovery, and downstream workflow integration.
  • Build and optimize high-throughput antibody discovery pipelines to improve efficiency, hit rate, and diversity while maintaining robustness and reproducibility.
  • Support antibody sequence generation and analysis, including single-cell RT-PCR, VH/VL amplification and sequencing, and use bioinformatic tools for candidate selection and hit-list generation.
  • Serve as a technical lead or project owner, mentor junior scientists, and drive team capability building.
  • Evaluate and integrate emerging technologies, define antibody discovery strategies, and support key project milestone decisions.
  • For senior scope, develop, document, and maintain SOPs and QC checkpoints across immunization, hybridoma, and single B cell workflows; deliver traceable records, data packages, and technical summaries.
  • For senior scope, support platform operational readiness through training, key consumables planning, and vendor/equipment coordination to ensure stable throughput and data consistency on high-throughput single-cell screening platforms.
  • Perform other duties as assigned in alignment with project and business needs.

Desired Qualifications

  • Experience with single B-cell antibody discovery, including single-cell sorting using microfluidics or FACS and VH/VL sequencing from single cells.
  • Experience with high-throughput antibody discovery platforms such as Hypercell or similar systems and understanding of related workflows.
  • NGS data analysis.
  • Antibody engineering, including humanization and affinity maturation.
  • Experience with bispecific or multispecific antibodies.

About the Company

Angitia

Clinical-stage biotech developing bone therapeutics

Angitia Biopharmaceuticals develops biologic therapies for serious musculoskeletal diseases, with multiple candidates in Phase 2 and Phase 3. Its bispecific antibodies and other biologics aim to both stimulate bone formation and inhibit bone degradation to improve skeletal health. The company differentiates itself through deep bone biology expertise, translational medicine experience, and global research collaborations that support clinical progress. The aim is to deliver new treatments that improve structural outcomes and quality of life while advancing toward regulatory milestones.

Company size
51-200
Company stage
Series D
Total funding
$366M
Headquarters
Los Angeles, CA
Founded
2018

Recently Posted Jobs

Explore more opportunities at Angitia

See more jobs